Patent ID: 6545032
Filing Date: 2003-04-08
Classification: C07D,C40B

Abstract:
A compound having a structure corresponding to that shown in Formula I, below, or a pharmaceutically acceptable salt thereof: wherein:R1 and R2 are independently selected from the group consisting of a hydrido, methyl, benzyl, 2-butyl, aminobutyl, N,N-dimethylaminobutyl, N-methylaminobutyl, N-methyl-N-benzylaminobutyl, 2-methylpropyl, methylsulfinylethyl, methylthioethyl, N,N-dimethylaminoethyl, N,N-dimethylaminopropyl, N,N,N-trimethylguanidinopropyl, N,N,N-tribenzylguanidinopropyl, N,N-dibenzylguanidinopropyl, N-methylguanidinopropyl, hydroxymethyl, 1-hydroxyethyl, 2-propyl, N-methyl-3-indolylmethyl, 4-methoxybenzyl, 4-hydroxybenzyl, propyl, butyl, cyclohexylmethyl, phenyl, 2-naphthylmethyl, and a 4-imidazolylmethyl substituent; and R3 is selected from the group consisting of a hydrido, C1-C10 alkyl, C1-C10 substituted alkyl, C2-C10 alkenyl, C2-C10 substituted alkenyl, C2-C10 alkynyl, C2-C10 substituted alkynyl, C3-C7 substituted cycloalkyl, phenyl, C7-C16 phenylalkyl, C7-C16 phenylalkenyl, C7-C16 phenylalkenyl and a C7-C16 substituted phenylalkenyl group.